Term
|
Definition
| IDSA/ATS Guidelines for CAP in Adults, 2007 |
|
|
Term
|
Definition
| Macrolide: Moxifloxacin 400mg qd x7-14d |
|
|
Term
| CAP outpatient w/ comorbidities treatment |
|
Definition
Beta-lactam + Macrolide
Amox/clav 2g BID + Clarithromycin 250mg q 12 OR 1000mg ER QD
OR Fluoroquinolone - Levofloxacin 750mg x7-10d |
|
|
Term
|
Definition
beta-lactam s/a cephalosporin + macrolide
Ceftriaxone 1-2g QD-bid + Clarithromycin 250mg q 12 OR 1000mg ER QD
OR fluoroquinolone alone
levofloxacin 750mg x5d |
|
|
Term
|
Definition
beta-lactam (3rd gen ceph or beta-lactam w/ beta-lactamase inhibitor) + macrolide OR + fluoroquinolone
Ceftriaxone 1-2g QD-bid OR Unasyn (amp/sul) 1.5-3g q6h + azithromycin IV 500mg qd x7-10d OR levofloxacin 750mg x5d |
|
|
Term
| Name the antipseudomonal antibiotics |
|
Definition
piperacillin/tazobactam
ticarcillin
ceftazidime
cefepime
meropenem
imipenem/cilistatin
dorapenem
aztreonam
amikacin
tobramycin
(gentamicin)
ciprofloxacin + other fq's |
|
|
Term
|
Definition
| Treatment of Tuberculosis, 2003 (IDSA, ATS, CDC) |
|
|
Term
|
Definition
First 8 weeks (all QD or 5d/wk if DOT)
INH 300mg (5mg/kg/d up to 300mg)
RIF 600mg (10mg/kg/d up to 600mg)
PZA 2000mg
EMB 1600mg - drop if resistance or after 2mos
next 18 weeks:
INH 300mg
RIF 600mg |
|
|
Term
|
Definition
| Surviving sepsis campaign guidelines, 2008 |
|
|
Term
|
Definition
IV antibacterial therapy for 14+ days or 4-6 weeks if endocarditis
Vancomycin 10-15 mg/kg IV q12-24h, monitor for trough 5-15mg (15-20 if severe)
Reassess in 48-72 hours; appropriate cultures for directed therapy |
|
|
Term
|
Definition
| Guidelines for the use of antiretroviral agents in HIV-1 infected adults & adolescents, 2008 |
|
|
Term
|
Definition
Tenofovir/emtricitabine (Truvada)
Zidovudine/lamivudine (Combivir) |
|
|
Term
|
Definition
NRTI 2 drug backbone
+ atazanavir +l/d ritonavir
OR + fosamprenavir +l/d ritonavir BID
OR + lopinavir/ritonavir (Kaletra) BID |
|
|
Term
|
Definition
NRTI 2-drug backbone
+ Efavirenz
(Atripla = tenofovir + emtricitabine + efavirenz) |
|
|
Term
|
Definition
those that end in "-avir"
EXCEPT abacavir |
|
|
Term
|
Definition
those that end in "-ine"
+abacavir
+tenofovir |
|
|
Term
|
Definition
Delaviridine
Efavirenz
Nevirapine |
|
|
Term
|
Definition
| Guidelines for subdural empyema & brain abscess treatment |
|
|
Term
|
Definition
surgical drainage
Ceftriaxone 2g IV q12h
Cefotaxime 2 q 4-6h
Metronidazole 7.5mg/kg IV q6h for bacteroides fragelis
x4-8wks |
|
|
Term
| Acute Otitis Externa Guidelines |
|
Definition
| Clinical practice guidelines: acute otitis externa, 2006 |
|
|
Term
|
Definition
Ofloxacin 10 gtts to affected ear qd x7d
Ciprofloxaxin/dexamethasone 4gtts bid to affected ear x7days
Systemic ABX for malignant AOE |
|
|
Term
|
Definition
| Have dr. put in ketoconazole cream or ointment then check at 1-2 days (for rxn & efficacy) and 1 week, rpt if necessary |
|
|
Term
|
Definition
| Practice guidelines for the management of bacterial meningitis. IDIS guidelines. 2004 |
|
|
Term
| Meningitis empirical therapy for <1mo |
|
Definition
| Ampicillin 100-400mg/kg/d divided q6h plus cefotaxime 100-200mg/kq/d q8-12h OR ampicillin plus an aminoglycoside 2.5mg/kg q12h |
|
|
Term
| Meningitis empirical therapy for 1mo-50yr |
|
Definition
Vancomycin 15mg/kq q6h for kids/500-750 q6h for adults plus a third-generation cephalosporin (ceftriaxone 2-4g/d divided q12-24h)
dexamethasone 0.15mg/kg q6h x2-4d w/ first dose of ABX |
|
|
Term
| Meningitis empirical treatment >50yo |
|
Definition
| Vancomycin 500-750mg q6h plus ampicillin 150-250mg/kg/d divided every 3-4h, max 6-12g/d plus a third-generation cephalosporin (ceftriaxone 2-4g divided q12-24h) |
|
|
